Skip to main content
Acta Crystallographica Section E: Crystallographic Communications logoLink to Acta Crystallographica Section E: Crystallographic Communications
. 2018 Aug 21;74(Pt 9):1276–1280. doi: 10.1107/S2056989018011404

A structural study of 2,4-di­methyl­aniline derivatives

Samuel C Penner a, Maryam Kalvandi a, Jamie S Ritch a,*
PMCID: PMC6127724  PMID: 30225116

The crystal structures of two aromatic amines are presented: a hydrogen-bonded brominated aniline, and a piperizine derivative.

Keywords: crystal structure, reactivity studies, hydrogen bonding, anilines, piperazines

Abstract

Crystallographic studies of nitro­gen-containing small mol­ecules aid in the elucidation of their structure–activity relationships and modes of aggregation. In this study, two previously synthesized mol­ecules are crystallographically characterized for the first time. Reaction of 2,4-di­methyl­aniline with N-bromo­succinimide affords the ortho-brominated derivative 2-bromo-4,6-di­methyl­aniline (1; C8H10BrN), which sublimates in vacuo to afford crystals featuring hydrogen-bonded chains as well as Type I halogen–halogen inter­actions. Conversely, alkyl­ation of two equivalents of 2,4-di­methyl­aniline with 1,2-di­bromo­ethane affords a separable mixture of N,N′-bis­(2,4-di­methyl­phen­yl)piperazine (2; C20H26N2), which was crystallographically characterized, as well as N,N′-bis­(2,4-di­methyl­phen­yl)ethyl­enedi­amine (3).

Chemical context  

Anilines are important building blocks for value-added chemicals such as indoles, which feature prominently in therapeutic agents (Humphrey & Kuethe, 2006). Polyaniline, formed by oxidative coupling of aniline, is a valuable conductive polymer used in advanced materials research (Kang et al., 1998). As they are prone to engage in hydrogen bonding, anilines have also been utilized in crystal engineering studies (Mukherjee et al., 2014). The piperazine functional group is present in a number of active pharmaceutical ingredients. In particular, the widely used anti­fungal agent itracona­zole (Grant & Clissold, 1989), and anti­bacterial ciprofloxacin (Hooper & Wolfson, 1991) feature piperazine structural units with aryl-group substitution. We have an inter­est in constructing N-heterocyclic carbenes (NHCs) and NHC-derived ligands, which often feature N-aryl groups derived from substituted anilines. Halogenated NHCs can be utilized to fine-tune the steric and electronic properties of transition metal catalysts. It has been demonstated that the presence of fluorine on an aryl group of an NHC ligand influences the E/Z selectivity of a ruthenium cross-metathesis catalyst (Xu et al., 2017). In our efforts to prepare NHC ligands, anilines and N,N′-di­aryldi­amines are commonly used starting materials or synthetic inter­mediates.

In this study, we report the crystallographic characterization of two compounds derived from 2,4-di­methyl­aniline: 2-bromo-4,6-di­methyl­aniline (1) and N,N′-bis­(2,4-di­methyl­phen­yl)piperazine (2). Though available from many commercial suppliers, the crystal structure of 2-bromo-4,6-di­methyl­aniline (1) has not been previously disclosed. Only a few reports of compound 2 can be found in the literature. An early publication (Tikhomirova, 1971) describes the reaction of 2-(2,4-di­methyl­anilino)ethanol with pyridinium chloride, which generates a mixture of 2,4-di­methyl­aniline and the piperazine 2, which was characterized only by elemental analysis, melting point, and boiling point. More recently, piperazine 2 was obtained as a trace by-product in the production of 2-(2,4-di­methyl­anilino)ethanol via palladium-mediated hydrogen autotransfer between 2,4-di­methyl­aniline and ethyl­ene glycol (Llabres-Campaner et al., 2017), and characterized by NMR and IR spectroscopy in addition to high resolution mass spectrometry. No X-ray structural data for compound 2 have been previously disclosed.graphic file with name e-74-01276-scheme1.jpg

Structural commentary  

The solid-state structure of 1 obtained by slow sublimation is depicted in Fig. 1. Two independent mol­ecules are present in the asymmetric unit, which are hydrogen bonded (Table 1) to each other [d(N⋯N) = 3.172 (5) Å] within the P21/c space group. The two independent mol­ecules exhibit C—Br and C—N bond lengths that are equal within experimental error [1.910 (3)–1.912 (3) Å and 1.394 (4)–1.394 (5) Å, respectively]. The angle between the two mean planes passing through the aromatic rings of the two independent molecules is 80.6 (2)°. The hydrogen atoms on each nitro­gen centre that are not involved in the chains formed by the N—H⋯N interactions are oriented towards the ortho bromine atoms on the aromatic rings. These intra­molecular hydrogen bonds feature donor-acceptor distances of 3.082 (4) and 3.094 (4) Å.

Figure 1.

Figure 1

Displacement ellipsoid plot (50% probability) of the asymmetric unit of compound 1.

Table 1. Hydrogen-bond geometry (Å, °) for 1 .

D—H⋯A D—H H⋯A DA D—H⋯A
N1—H1A⋯N2 0.80 (4) 2.44 (4) 3.172 (5) 154 (3)
N1—H1B⋯Br1 0.79 (4) 2.68 (4) 3.094 (4) 115 (4)
N2—H2A⋯N1i 0.81 (4) 2.43 (4) 3.155 (5) 149 (4)
N2—H2B⋯Br2 0.75 (4) 2.70 (4) 3.082 (4) 114 (3)

Symmetry code: (i) Inline graphic.

X-ray diffraction analysis of 2 revealed a solvent-free structure in the P21 space group (Fig. 2). The asymmetric unit contains one pseudo-C i symmetric mol­ecule. The central N2C4 ring exhibits a chair conformation. Compound 2 represents the first crystallographically characterized di­aryl­piperazine with methyl groups on the aromatic substituents. The aromatic rings are twisted relative to the N2C4 mean plane, forming angles of 46.8 (1) and 56.9 (1)° for C5–C10 and C13–C18, respectively.

Figure 2.

Figure 2

Displacement ellipsoid plot (50% probability) of the asymmetric unit of compound 2. Hydrogen atoms are omitted for clarity.

Supra­molecular features  

Each amino group in compound 1 provides one donor and one acceptor site for the hydrogen-bond inter­actions (Table 1), and chains are observed to form by translation along the crystallographic b axis (Fig. 3). Additionally, the bromine atoms from one of the two independent mol­ecules exhibit weak van der Waals inter­actions to the equivalent sites on adjacent chains, related by an inversion centre (Fig. 4). The distance for this inter­action is 3.537 (1) Å (sum of van der Waals radii for bromine: 3.70 Å; Bondi, 1964). As the two C—Br⋯Br bond angles are equal (ca 153 °), this classifies as a Type I halogen–halogen inter­action (Cavallo et al., 2016). This type is generally accepted as a dispersion inter­action, as opposed to Type II inter­actions which are weakly electrostatic in nature and require RXX angles of 90 and 180°. No π–π inter­actions are present in the structure. No significant inter­molecular inter­actions are observed in the crystal packing motif of 2 (Fig. 5).

Figure 3.

Figure 3

Packing diagram for compound 1. Carbon-bound hydrogen atoms are omitted for clarity.

Figure 4.

Figure 4

Type I bromine-bromine inter­action in the packing of compound 1. Carbon-bound hydrogen atoms are omitted for clarity.

Figure 5.

Figure 5

Packing diagram for compound 2. Hydrogen atoms are omitted for clarity.

Database survey  

The packing motif of compound 1 makes an inter­esting contrast to the structure of the less substituted analogue 2-bromo­aniline, which crystallizes from the melt in the trigonal P31 space group (Nayak et al., 2009). Helical arrangements are formed with each mol­ecule involved in inter­molecular N—H⋯N hydrogen bonds [DA distance of 3.162 (6) Å] and a weaker bromine⋯bromine inter­action (Br⋯Br distance of 3.637 (1) Å), both observed along the 31 screw axes, and with additional intra­molecular N–H⋯Br inter­actions. In the case of the more sterically hindered deriv­ative 1, this arrangement is not feasible and chains are instead adopted.

Most of the crystallographically characterized di­aryl­piperazines feature the chair conformation; a few have been determined in the twist-boat form (Wirth et al., 2012). Whereas the phenyl groups of piperazine 2 are twisted relative to the N2C4 mean plane, the structure of the less substituted N,N′-di­phenyl­piperazine, which crystallizes in the Pbca space group, exhibits phenyl groups closer to being in conjugation with the nitro­gen lone pairs (Wirth et al., 2012; Safko & Pike, 2012). The sum of the bond angles around nitro­gen is quite similar between the two structures (2: 338–341°; N,N′-di­phenyl­piperazine: 343°), though the N–Car­yl bond lengths are slightly shortened in the phenyl-substituted analogue [2: 1.426 (3)–1.431 (3) Å; N,N′-di­phenyl­piperazine: 1.4157 (15) Å], indicating that resonance delocalization is a perhaps a minor effect, if present, while packing effects likely dominate. The structures of 2 and the phenyl analogue are overlaid in Fig. 6 for visual comparison.

Figure 6.

Figure 6

Structure of compound 2 overlaid with N,N′-di­phenyl­piperazine (CCDC refcode WAQNUZ01).

Synthesis and crystallization  

We prepared compound 1 by electrophilic aromatic bromination of the parent aniline, as reported previously for related compounds (Das et al., 2007). The resultant red-brown solid was reasonably pure by 1H NMR, however it was easily sublimated to afford very pure colourless material, leaving behind oily reddish-brown impurities.

The piperazine compound 2 was unexpectedly obtained as a by-product during the synthesis of N,N′-bis­(2,4-di­methyl­phen­yl)ethyl­enedi­amine (3) via a condensation reaction. Compound 3 is evidently able to compete with 2,4-di­methyl­aniline as a nucleophile towards 1,2-di­bromo­ethane, once formed. Both desired main product 3 and by-product 2 were isolated after separation by column chromatography.

Synthetic protocols were conducted under ambient conditions using ACS-grade solvents. All chemicals were obtained from commercial sources and used as received. NMR spectra were collected using a Bruker 400 MHz Avance III spectrometer. 1H and 13C resonances are referenced to residual CHCl3 or CDCl3, respectively, using the reported values relative to SiMe4 (Fulmer et al., 2010).

Preparation of 2-bromo-4,6-di­methyl­aniline (1)  

A 100 mL round-bottom flask equipped with a magnetic stir bar was charged with N-bromo­succinimide (3.4896 g, 19.607 mmol), ammonium acetate (0.1583 g, 2.054 mmol), and aceto­nitrile (60 mL). The reagent 2,4-di­methyl­aniline (2.4297 g, 20.050 mmol) was added slowly, by pipette. The resulting mixture was left to stir at room temperature for 90 min. The solvent was removed under vacuum to produce a reddish-brown solid. Water (45 mL) and di­chloro­methane (45 mL) were added, and the mixture was transferred to a separatory funnel. The organic layer was separated and washed with water (3 × 30 mL), saturated sodium thio­sulfate (30 mL), and brine (30 mL). After drying the organic layer with magnesium sulfate, the mixture was filtered and the volatiles removed under vacuum to afford a brown crystalline solid (3.2723 g, 83.42%). 1H NMR (CDCl3, 400 MHz): δ 7.15 (s, 1H), 7.14 (s, 1H), 3.93 (s, 2H), 2.22 (s, 3H), 2.21 (s, 3H). The procedure was based on one reported for similar aniline derivatives (Das et al., 2007). The product can be purified by sublimation under static vacuum with heating to 308 K for 3 d. Large X-ray quality crystals of the product were obtained by slow sublimation under ambient conditions in a capped glass vial containing the crude product, over a period of months.

Preparation of N,N′-bis­(2,4-di­methyl­phen­yl)piperazine (2) and N,N′-bis­(2,4-di­methyl­phen­yl)ethyl­enedi­amine (3)  

A 100 mL round-bottom flask equipped with a magnetic stir bar was charged with 2,4-di­methyl­aniline (9.21 mL, 74.5 mmol), 1,2-di­bromo­ethane (3.21 mL, 37.3 mmol), and N,N′-diiso­propyl­ethyl­amine (12.98 mL, 74.5 mmol), and fitted with a reflux condenser and drying tube. The mixture was heated to 403 K for 4 h, then cooled to room temperature affording a red solid mass. To this was added H2O (50 mL) before extraction with CH2Cl2 (30 mL). The organic phase was washed with H2O (50 mL), and to the combined aqueous extracts was added 1 M NaOH(aq) (40 mL), and this mixture was extracted with CH2Cl2 (50 mL). The combined organic extracts were washed with H2O (30 mL) and brine (30 mL), dried over MgSO4, deca­nted into a round-bottom flask, and dried under vacuum to afford a dark orange–red liquid. Addition of hexa­nes (40 mL) resulted in the precipitation of crystalline material. The solid material was redissolved by warming the hexa­nes, and the resultant clear red solution was stored overnight at 238 K. The mother liquor was deca­nted and the remaining solid material was washed with cold hexa­nes (3 × 3 mL) and dried under vacuum to afford a beige solid (5.4730 g). NMR data indicated that the product was a 90:10 mol% mixture of 1,2-di­amine 3 and piperazine 2, obtained with a 69% yield of products based on 1,2-di­bromo­ethane. Separation of the compounds was achieved by silica gel flash chromatography. Elution of 1.3223 g of a mixture with CH2Cl2 afforded piperazine 2 as a pale-tan crystalline solid (R f = 0.75, 124.0 mg, 60% recovery) and di­amine 3 as a pale-yellow solid (R f = 0.21, 851.4 mg, 84% recovery). The 1H and 13C chemical shifts and assignments for di­amine in CDCl3 differed from the reported values (Türkmen & Çetinkaya, 2006). Di­amine 3: 1H NMR (CDCl3): δ 6.96 (d, 3 J HH = 8.1 Hz, 2H, aromatic 5-H), 6.91 (s, 2H, aromatic 3-H), 6.61 (d, 3 J HH = 8.1 Hz, 2H, aromatic 6-H), 3.61 (br s, 2H, NH), 3.47 (s, 4H, CH2), 2.25 (s, 6H, aromatic 4-CH3), 2.11 (s, 6H, aromatic 2-CH3). 13C{1H} NMR (CDCl3): δ 144.0 (s), 131.3 (s), 127.6 (s), 126.8 (s), 122.8 (s), 110.4 (s), 43.8 (s, CH2), 20.5 (s), 17.7 (s). Piperazine 2: 1H NMR (CDCl3): δ 7.03 (s, 2H, aromatic CH), 7.01 (s, 4H, aromatic CH), 3.04 (s, 8H, CH2), 2.33 (s, 6H, CH3), 2.30 (s, 6H, CH3). 13C{1H} NMR (CDCl3): δ 149.5 (s), 132.9 (s), 132.8 (s), 132.0 (s), 127.2 (s), 119.3 (s), 52.8 (s), 20.9 (s), 18.0 (s). The procedure was based on that used for the fluoro analogue (Day et al., 2011). Crystals of piperazine 2 were grown by slow evaporation of a toluene solution of the compound, at room temperature.

Refinement details  

Crystal data, data collection and structure refinement details are summarized in Table 2. The N—H protons of compound 1 were located in the difference map and refined freely. The piperazine 2 crystallized in the non-centric group P21; no heavy atoms are present in the structure, therefore the Flack parameter was not calculated. Carbon-bound hydrogen atoms were placed in calculated positions (C—H = 0.95–0.99 Å) and refined according to a riding model, with fixed U iso values of 1.2 times (CH and CH2 groups) and 1.5 times (CH3 groups) the parent atom.

Table 2. Experimental details.

  C8H10BrN C20H26N2
Crystal data
M r 200.08 294.43
Crystal system, space group Monoclinic, P21/c Monoclinic, P21
Temperature (K) 150 150
a, b, c (Å) 16.4359 (10), 5.1917 (3), 20.5792 (11) 7.6563 (2), 13.2685 (4), 8.3688 (2)
β (°) 110.748 (4) 96.968 (2)
V3) 1642.15 (17) 843.89 (4)
Z 8 2
Radiation type Mo Kα Mo Kα
μ (mm−1) 4.93 0.07
Crystal size (mm) 0.28 × 0.15 × 0.08 0.28 × 0.15 × 0.08
 
Data collection
Diffractometer Bruker APEXII CCD Bruker APEXII CCD
Absorption correction Numerical (SADABS; Bruker, 2015) Numerical (SADABS; Bruker, 2015)
T min, T max 0.542, 0.746 0.894, 0.954
No. of measured, independent and observed [I > 2σ(I)] reflections 17969, 2903, 2170 13424, 3289, 2588
R int 0.052 0.074
(sin θ/λ)max−1) 0.595 0.625
 
Refinement
R[F 2 > 2σ(F 2)], wR(F 2), S 0.030, 0.069, 1.00 0.040, 0.095, 1.05
No. of reflections 2903 3289
No. of parameters 201 203
No. of restraints 0 1
H-atom treatment H atoms treated by a mixture of independent and constrained refinement H-atom parameters constrained
Δρmax, Δρmin (e Å−3) 0.45, −0.38 0.20, −0.19

Computer programs: APEX2 and SAINT (Bruker, 2015), SHELXT (Sheldrick, 2015a ), SHELXL (Sheldrick, 2015b ) and OLEX2 (Dolomanov et al., 2009).

Supplementary Material

Crystal structure: contains datablock(s) 1, 2. DOI: 10.1107/S2056989018011404/lh5879sup1.cif

e-74-01276-sup1.cif (975.1KB, cif)

Structure factors: contains datablock(s) 1. DOI: 10.1107/S2056989018011404/lh58791sup2.hkl

e-74-01276-1sup2.hkl (232.2KB, hkl)

Structure factors: contains datablock(s) 2. DOI: 10.1107/S2056989018011404/lh58792sup3.hkl

e-74-01276-2sup3.hkl (262.5KB, hkl)

CCDC references: 1861254, 1861253

Additional supporting information: crystallographic information; 3D view; checkCIF report

Acknowledgments

Dr David Herbert (Department of Chemistry, University of Manitoba) is thanked for access to a single-crystal X-ray diffractometer.

supplementary crystallographic information

2-Bromo-4,6-dimethylaniline (1). Crystal data

C8H10BrN F(000) = 800
Mr = 200.08 Dx = 1.619 Mg m3
Monoclinic, P21/c Mo Kα radiation, λ = 0.71073 Å
a = 16.4359 (10) Å Cell parameters from 6401 reflections
b = 5.1917 (3) Å θ = 2.7–27.3°
c = 20.5792 (11) Å µ = 4.93 mm1
β = 110.748 (4)° T = 150 K
V = 1642.15 (17) Å3 Prism, colourless
Z = 8 0.28 × 0.15 × 0.08 mm

2-Bromo-4,6-dimethylaniline (1). Data collection

Bruker APEXII CCD diffractometer 2170 reflections with I > 2σ(I)
φ and ω scans Rint = 0.052
Absorption correction: numerical (SADABS; Bruker, 2015) θmax = 25.0°, θmin = 2.7°
Tmin = 0.542, Tmax = 0.746 h = −19→19
17969 measured reflections k = −6→6
2903 independent reflections l = −24→24

2-Bromo-4,6-dimethylaniline (1). Refinement

Refinement on F2 Primary atom site location: dual
Least-squares matrix: full Hydrogen site location: mixed
R[F2 > 2σ(F2)] = 0.030 H atoms treated by a mixture of independent and constrained refinement
wR(F2) = 0.069 w = 1/[σ2(Fo2) + (0.0241P)2 + 3.2572P] where P = (Fo2 + 2Fc2)/3
S = 1.00 (Δ/σ)max = 0.001
2903 reflections Δρmax = 0.45 e Å3
201 parameters Δρmin = −0.38 e Å3
0 restraints

2-Bromo-4,6-dimethylaniline (1). Special details

Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.

2-Bromo-4,6-dimethylaniline (1). Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)

x y z Uiso*/Ueq
Br1 0.97945 (2) 0.20330 (8) 0.56141 (2) 0.03211 (12)
N1 0.8334 (2) 0.6135 (7) 0.52086 (17) 0.0268 (7)
H1A 0.815 (2) 0.756 (8) 0.5140 (19) 0.020 (11)*
H1B 0.871 (3) 0.593 (8) 0.505 (2) 0.035 (13)*
C1 0.8515 (2) 0.5157 (6) 0.58759 (17) 0.0194 (7)
C2 0.9120 (2) 0.3209 (7) 0.61459 (17) 0.0214 (8)
C3 0.9268 (2) 0.2078 (7) 0.67863 (17) 0.0228 (8)
H3 0.968810 0.074670 0.694815 0.027*
C4 0.8800 (2) 0.2901 (7) 0.71895 (17) 0.0222 (7)
C5 0.8196 (2) 0.4857 (7) 0.69261 (17) 0.0216 (8)
H5 0.787150 0.543673 0.719926 0.026*
C6 0.8041 (2) 0.6005 (7) 0.62857 (18) 0.0208 (8)
C7 0.8930 (2) 0.1658 (8) 0.78885 (19) 0.0315 (9)
H7A 0.881827 −0.019629 0.782470 0.047*
H7B 0.852611 0.242654 0.808743 0.047*
H7C 0.952953 0.194196 0.820356 0.047*
C8 0.7372 (2) 0.8172 (7) 0.60306 (18) 0.0232 (8)
H8A 0.766500 0.975665 0.597582 0.035*
H8B 0.708709 0.845803 0.637008 0.035*
H8C 0.693420 0.768935 0.558245 0.035*
Br2 0.73280 (2) 0.70006 (8) 0.33028 (2) 0.03345 (12)
N2 0.7421 (2) 1.1155 (7) 0.43964 (19) 0.0262 (7)
H2A 0.745 (3) 1.262 (8) 0.454 (2) 0.026 (12)*
H2B 0.771 (3) 1.104 (8) 0.419 (2) 0.024 (12)*
C9 0.6585 (2) 1.0176 (7) 0.40744 (17) 0.0217 (8)
C10 0.6405 (2) 0.8241 (7) 0.35792 (17) 0.0220 (8)
C11 0.5595 (2) 0.7119 (7) 0.32828 (17) 0.0254 (8)
H11 0.550493 0.580042 0.294449 0.030*
C12 0.4915 (2) 0.7929 (7) 0.34820 (18) 0.0264 (8)
C13 0.5085 (2) 0.9868 (7) 0.39782 (17) 0.0237 (8)
H13 0.462454 1.043560 0.412055 0.028*
C14 0.5893 (2) 1.1007 (7) 0.42741 (17) 0.0218 (8)
C15 0.4027 (2) 0.6683 (8) 0.3184 (2) 0.0364 (10)
H15B 0.371137 0.740538 0.272303 0.055*
H15C 0.370039 0.701668 0.349132 0.055*
H15A 0.409549 0.482129 0.314386 0.055*
C16 0.6042 (2) 1.3165 (6) 0.48222 (16) 0.0191 (7)
H16C 0.652570 1.268841 0.524484 0.029*
H16A 0.551292 1.339629 0.493238 0.029*
H16B 0.618051 1.477773 0.463684 0.029*

2-Bromo-4,6-dimethylaniline (1). Atomic displacement parameters (Å2)

U11 U22 U33 U12 U13 U23
Br1 0.0301 (2) 0.0367 (2) 0.0358 (2) 0.00185 (18) 0.01951 (18) −0.00371 (18)
N1 0.0294 (19) 0.0256 (19) 0.0247 (17) −0.0004 (16) 0.0088 (16) 0.0017 (15)
C1 0.0179 (18) 0.0172 (18) 0.0196 (18) −0.0040 (14) 0.0024 (15) 0.0002 (14)
C2 0.0168 (17) 0.0228 (19) 0.0256 (19) −0.0034 (16) 0.0089 (15) −0.0073 (16)
C3 0.0155 (16) 0.0221 (18) 0.0278 (19) 0.0014 (15) 0.0041 (15) 0.0003 (16)
C4 0.0169 (17) 0.0249 (18) 0.0232 (18) −0.0065 (16) 0.0053 (14) −0.0025 (16)
C5 0.0162 (17) 0.0264 (19) 0.0228 (18) −0.0023 (15) 0.0078 (15) −0.0085 (16)
C6 0.0161 (17) 0.0178 (17) 0.0258 (19) −0.0015 (15) 0.0042 (15) −0.0035 (16)
C7 0.029 (2) 0.037 (2) 0.030 (2) −0.0012 (18) 0.0115 (17) 0.0041 (18)
C8 0.0238 (18) 0.0161 (17) 0.0259 (18) −0.0007 (16) 0.0040 (15) −0.0055 (16)
Br2 0.0361 (2) 0.0404 (2) 0.0305 (2) 0.00730 (19) 0.02002 (18) 0.00411 (18)
N2 0.0225 (18) 0.0237 (19) 0.0312 (19) −0.0051 (15) 0.0081 (16) −0.0007 (16)
C9 0.0233 (19) 0.0205 (19) 0.0193 (18) 0.0011 (15) 0.0050 (15) 0.0071 (15)
C10 0.027 (2) 0.0234 (19) 0.0193 (17) 0.0047 (16) 0.0126 (15) 0.0056 (16)
C11 0.031 (2) 0.0235 (19) 0.0196 (17) −0.0008 (17) 0.0069 (16) −0.0017 (16)
C12 0.0242 (19) 0.0282 (19) 0.0230 (18) 0.0005 (17) 0.0037 (15) 0.0060 (17)
C13 0.0226 (19) 0.027 (2) 0.0226 (19) 0.0063 (16) 0.0097 (15) 0.0062 (16)
C14 0.0257 (19) 0.0193 (17) 0.0185 (17) 0.0037 (15) 0.0052 (15) 0.0030 (15)
C15 0.029 (2) 0.042 (3) 0.033 (2) −0.0064 (19) 0.0049 (18) 0.000 (2)
C16 0.0192 (17) 0.0139 (17) 0.0210 (17) 0.0037 (15) 0.0031 (14) 0.0038 (15)

2-Bromo-4,6-dimethylaniline (1). Geometric parameters (Å, º)

Br1—C2 1.912 (3) Br2—C10 1.910 (3)
N1—H1A 0.80 (4) N2—H2A 0.81 (4)
N1—H1B 0.79 (4) N2—H2B 0.75 (4)
N1—C1 1.394 (4) N2—C9 1.394 (5)
C1—C2 1.390 (5) C9—C10 1.386 (5)
C1—C6 1.406 (5) C9—C14 1.407 (5)
C2—C3 1.383 (5) C10—C11 1.382 (5)
C3—H3 0.9500 C11—H11 0.9500
C3—C4 1.384 (5) C11—C12 1.385 (5)
C4—C5 1.389 (5) C12—C13 1.390 (5)
C4—C7 1.521 (5) C12—C15 1.513 (5)
C5—H5 0.9500 C13—H13 0.9500
C5—C6 1.386 (5) C13—C14 1.382 (5)
C6—C8 1.531 (5) C14—C16 1.546 (5)
C7—H7A 0.9800 C15—H15B 0.9800
C7—H7B 0.9800 C15—H15C 0.9800
C7—H7C 0.9800 C15—H15A 0.9800
C8—H8A 0.9800 C16—H16C 0.9800
C8—H8B 0.9800 C16—H16A 0.9800
C8—H8C 0.9800 C16—H16B 0.9800
H1A—N1—H1B 111 (4) H2A—N2—H2B 108 (4)
C1—N1—H1A 117 (3) C9—N2—H2A 116 (3)
C1—N1—H1B 115 (3) C9—N2—H2B 115 (3)
N1—C1—C6 120.5 (3) N2—C9—C14 120.8 (3)
C2—C1—N1 122.1 (3) C10—C9—N2 122.1 (3)
C2—C1—C6 117.3 (3) C10—C9—C14 117.0 (3)
C1—C2—Br1 118.8 (3) C9—C10—Br2 118.6 (3)
C3—C2—Br1 117.9 (3) C11—C10—Br2 118.0 (3)
C3—C2—C1 123.3 (3) C11—C10—C9 123.4 (3)
C2—C3—H3 120.2 C10—C11—H11 120.2
C2—C3—C4 119.5 (3) C10—C11—C12 119.6 (3)
C4—C3—H3 120.2 C12—C11—H11 120.2
C3—C4—C5 117.7 (3) C11—C12—C13 117.7 (3)
C3—C4—C7 121.0 (3) C11—C12—C15 120.9 (3)
C5—C4—C7 121.4 (3) C13—C12—C15 121.4 (3)
C4—C5—H5 118.3 C12—C13—H13 118.5
C6—C5—C4 123.4 (3) C14—C13—C12 123.0 (3)
C6—C5—H5 118.3 C14—C13—H13 118.5
C1—C6—C8 120.5 (3) C9—C14—C16 120.0 (3)
C5—C6—C1 118.8 (3) C13—C14—C9 119.3 (3)
C5—C6—C8 120.7 (3) C13—C14—C16 120.7 (3)
C4—C7—H7A 109.5 C12—C15—H15B 109.5
C4—C7—H7B 109.5 C12—C15—H15C 109.5
C4—C7—H7C 109.5 C12—C15—H15A 109.5
H7A—C7—H7B 109.5 H15B—C15—H15C 109.5
H7A—C7—H7C 109.5 H15B—C15—H15A 109.5
H7B—C7—H7C 109.5 H15C—C15—H15A 109.5
C6—C8—H8A 109.5 C14—C16—H16C 109.5
C6—C8—H8B 109.5 C14—C16—H16A 109.5
C6—C8—H8C 109.5 C14—C16—H16B 109.5
H8A—C8—H8B 109.5 H16C—C16—H16A 109.5
H8A—C8—H8C 109.5 H16C—C16—H16B 109.5
H8B—C8—H8C 109.5 H16A—C16—H16B 109.5

2-Bromo-4,6-dimethylaniline (1). Hydrogen-bond geometry (Å, º)

D—H···A D—H H···A D···A D—H···A
N1—H1A···N2 0.80 (4) 2.44 (4) 3.172 (5) 154 (3)
N1—H1B···Br1 0.79 (4) 2.68 (4) 3.094 (4) 115 (4)
N2—H2A···N1i 0.81 (4) 2.43 (4) 3.155 (5) 149 (4)
N2—H2B···Br2 0.75 (4) 2.70 (4) 3.082 (4) 114 (3)

Symmetry code: (i) x, y+1, z.

1,4-Bis(2,4-dimethylphenyl)piperazine (2). Crystal data

C20H26N2 F(000) = 320
Mr = 294.43 Dx = 1.159 Mg m3
Monoclinic, P21 Mo Kα radiation, λ = 0.71073 Å
a = 7.6563 (2) Å Cell parameters from 4924 reflections
b = 13.2685 (4) Å θ = 2.5–31.6°
c = 8.3688 (2) Å µ = 0.07 mm1
β = 96.968 (2)° T = 150 K
V = 843.89 (4) Å3 Block, clear colourless
Z = 2 0.28 × 0.15 × 0.08 mm

1,4-Bis(2,4-dimethylphenyl)piperazine (2). Data collection

Bruker APEXII CCD diffractometer 2588 reflections with I > 2σ(I)
φ and ω scans Rint = 0.074
Absorption correction: numerical (SADABS; Bruker, 2015) θmax = 26.4°, θmin = 2.9°
Tmin = 0.894, Tmax = 0.954 h = −9→9
13424 measured reflections k = −16→16
3289 independent reflections l = −10→10

1,4-Bis(2,4-dimethylphenyl)piperazine (2). Refinement

Refinement on F2 Primary atom site location: dual
Least-squares matrix: full Hydrogen site location: inferred from neighbouring sites
R[F2 > 2σ(F2)] = 0.040 H-atom parameters constrained
wR(F2) = 0.095 w = 1/[σ2(Fo2) + (0.0509P)2] where P = (Fo2 + 2Fc2)/3
S = 1.05 (Δ/σ)max = 0.001
3289 reflections Δρmax = 0.20 e Å3
203 parameters Δρmin = −0.19 e Å3
1 restraint

1,4-Bis(2,4-dimethylphenyl)piperazine (2). Special details

Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.

1,4-Bis(2,4-dimethylphenyl)piperazine (2). Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)

x y z Uiso*/Ueq
N1 0.8569 (2) 0.56722 (15) 0.4969 (3) 0.0224 (5)
N2 0.6207 (2) 0.45272 (16) 0.6642 (3) 0.0220 (5)
C1 0.9201 (3) 0.4876 (2) 0.6112 (3) 0.0246 (6)
H1A 1.040068 0.504463 0.662098 0.029*
H1B 0.926270 0.423048 0.552878 0.029*
C2 0.7987 (3) 0.4762 (2) 0.7399 (3) 0.0259 (6)
H2A 0.841706 0.421380 0.814845 0.031*
H2B 0.797117 0.539467 0.802411 0.031*
C3 0.6774 (3) 0.5442 (2) 0.4243 (3) 0.0258 (6)
H3A 0.676846 0.480219 0.363429 0.031*
H3B 0.634424 0.598445 0.348234 0.031*
C4 0.5577 (3) 0.5352 (2) 0.5544 (4) 0.0268 (6)
H4A 0.557386 0.599282 0.614919 0.032*
H4B 0.435857 0.521120 0.505348 0.032*
C5 0.4986 (3) 0.41979 (19) 0.7690 (3) 0.0222 (6)
C6 0.3523 (3) 0.3616 (2) 0.7052 (3) 0.0209 (6)
C7 0.2394 (3) 0.3254 (2) 0.8102 (3) 0.0234 (6)
H7 0.140547 0.286476 0.767276 0.028*
C8 0.2643 (3) 0.3435 (2) 0.9749 (3) 0.0252 (6)
C9 0.4095 (3) 0.4009 (2) 1.0347 (4) 0.0302 (7)
H9 0.430569 0.414541 1.146814 0.036*
C10 0.5236 (3) 0.4385 (2) 0.9336 (3) 0.0275 (6)
H10 0.621291 0.478073 0.977545 0.033*
C11 0.3192 (3) 0.3355 (2) 0.5289 (3) 0.0264 (6)
H11A 0.254747 0.271661 0.515405 0.040*
H11B 0.431892 0.328848 0.485378 0.040*
H11C 0.249530 0.389040 0.471108 0.040*
C12 0.1416 (4) 0.3004 (2) 1.0852 (4) 0.0350 (7)
H12A 0.024784 0.290661 1.025118 0.052*
H12B 0.132978 0.346997 1.174735 0.052*
H12C 0.187303 0.235416 1.127501 0.052*
C13 0.9794 (3) 0.59108 (19) 0.3864 (3) 0.0212 (6)
C14 1.1194 (3) 0.65758 (19) 0.4351 (3) 0.0216 (6)
C15 1.2329 (3) 0.6837 (2) 0.3236 (3) 0.0231 (6)
H15 1.325513 0.729848 0.355421 0.028*
C16 1.2165 (3) 0.64531 (19) 0.1680 (4) 0.0251 (6)
C17 1.0792 (3) 0.5787 (2) 0.1236 (3) 0.0275 (6)
H17 1.065047 0.550702 0.018299 0.033*
C18 0.9624 (3) 0.5526 (2) 0.2311 (3) 0.0274 (6)
H18 0.868867 0.507338 0.197703 0.033*
C19 1.1465 (3) 0.7012 (2) 0.6018 (4) 0.0296 (7)
H19A 1.210157 0.652630 0.675487 0.044*
H19B 1.032038 0.715946 0.637638 0.044*
H19C 1.215095 0.763545 0.601050 0.044*
C20 1.3401 (3) 0.6774 (2) 0.0498 (4) 0.0307 (7)
H20A 1.290904 0.736048 −0.011167 0.046*
H20B 1.354809 0.621855 −0.024576 0.046*
H20C 1.454590 0.695166 0.108346 0.046*

1,4-Bis(2,4-dimethylphenyl)piperazine (2). Atomic displacement parameters (Å2)

U11 U22 U33 U12 U13 U23
N1 0.0194 (10) 0.0218 (12) 0.0258 (12) 0.0019 (8) 0.0017 (9) 0.0032 (10)
N2 0.0184 (10) 0.0228 (12) 0.0238 (12) 0.0004 (8) −0.0005 (9) 0.0036 (10)
C1 0.0180 (11) 0.0238 (13) 0.0311 (17) 0.0023 (10) −0.0007 (10) 0.0038 (12)
C2 0.0213 (11) 0.0271 (15) 0.0284 (16) −0.0012 (10) −0.0010 (10) 0.0042 (13)
C3 0.0204 (12) 0.0288 (14) 0.0276 (15) 0.0024 (10) 0.0003 (10) 0.0061 (12)
C4 0.0188 (12) 0.0265 (14) 0.0344 (17) 0.0025 (10) 0.0011 (11) 0.0062 (13)
C5 0.0200 (12) 0.0220 (14) 0.0244 (16) 0.0035 (9) 0.0015 (10) 0.0031 (11)
C6 0.0198 (12) 0.0211 (13) 0.0213 (14) 0.0044 (9) 0.0004 (10) 0.0006 (11)
C7 0.0195 (12) 0.0223 (14) 0.0276 (16) −0.0006 (10) 0.0000 (10) −0.0009 (12)
C8 0.0258 (12) 0.0217 (14) 0.0287 (16) 0.0004 (10) 0.0060 (11) −0.0009 (12)
C9 0.0348 (14) 0.0343 (16) 0.0214 (15) −0.0017 (12) 0.0031 (12) −0.0067 (13)
C10 0.0266 (13) 0.0244 (14) 0.0306 (16) −0.0053 (11) 0.0003 (11) −0.0030 (12)
C11 0.0222 (12) 0.0295 (15) 0.0269 (16) −0.0016 (11) 0.0004 (11) −0.0008 (13)
C12 0.0395 (15) 0.0368 (18) 0.0297 (18) −0.0049 (12) 0.0085 (13) −0.0013 (14)
C13 0.0171 (11) 0.0190 (13) 0.0271 (16) 0.0027 (9) 0.0012 (10) 0.0026 (11)
C14 0.0192 (11) 0.0221 (14) 0.0227 (15) 0.0038 (10) −0.0010 (10) 0.0013 (11)
C15 0.0208 (12) 0.0207 (13) 0.0264 (16) −0.0017 (10) −0.0025 (11) 0.0002 (11)
C16 0.0241 (13) 0.0235 (14) 0.0270 (16) 0.0029 (10) −0.0003 (11) 0.0027 (12)
C17 0.0301 (14) 0.0291 (15) 0.0227 (15) −0.0014 (11) 0.0006 (11) −0.0064 (12)
C18 0.0228 (12) 0.0275 (15) 0.0308 (17) −0.0056 (11) −0.0012 (11) −0.0030 (12)
C19 0.0266 (12) 0.0358 (17) 0.0261 (16) −0.0042 (11) 0.0026 (11) −0.0036 (13)
C20 0.0318 (14) 0.0351 (17) 0.0259 (17) −0.0037 (12) 0.0065 (12) −0.0024 (13)

1,4-Bis(2,4-dimethylphenyl)piperazine (2). Geometric parameters (Å, º)

N1—C1 1.466 (3) C9—C10 1.381 (4)
N1—C3 1.466 (3) C10—H10 0.9500
N1—C13 1.431 (3) C11—H11A 0.9800
N2—C2 1.465 (3) C11—H11B 0.9800
N2—C4 1.472 (3) C11—H11C 0.9800
N2—C5 1.426 (3) C12—H12A 0.9800
C1—H1A 0.9900 C12—H12B 0.9800
C1—H1B 0.9900 C12—H12C 0.9800
C1—C2 1.514 (4) C13—C14 1.410 (3)
C2—H2A 0.9900 C13—C18 1.388 (4)
C2—H2B 0.9900 C14—C15 1.393 (4)
C3—H3A 0.9900 C14—C19 1.502 (4)
C3—H3B 0.9900 C15—H15 0.9500
C3—C4 1.511 (4) C15—C16 1.390 (4)
C4—H4A 0.9900 C16—C17 1.390 (4)
C4—H4B 0.9900 C16—C20 1.511 (4)
C5—C6 1.411 (3) C17—H17 0.9500
C5—C10 1.390 (4) C17—C18 1.387 (4)
C6—C7 1.391 (4) C18—H18 0.9500
C6—C11 1.507 (4) C19—H19A 0.9800
C7—H7 0.9500 C19—H19B 0.9800
C7—C8 1.389 (4) C19—H19C 0.9800
C8—C9 1.390 (4) C20—H20A 0.9800
C8—C12 1.508 (4) C20—H20B 0.9800
C9—H9 0.9500 C20—H20C 0.9800
C3—N1—C1 109.8 (2) C5—C10—H10 119.3
C13—N1—C1 112.98 (18) C9—C10—C5 121.4 (2)
C13—N1—C3 115.7 (2) C9—C10—H10 119.3
C2—N2—C4 109.2 (2) C6—C11—H11A 109.5
C5—N2—C2 116.4 (2) C6—C11—H11B 109.5
C5—N2—C4 114.96 (19) C6—C11—H11C 109.5
N1—C1—H1A 109.5 H11A—C11—H11B 109.5
N1—C1—H1B 109.5 H11A—C11—H11C 109.5
N1—C1—C2 110.71 (19) H11B—C11—H11C 109.5
H1A—C1—H1B 108.1 C8—C12—H12A 109.5
C2—C1—H1A 109.5 C8—C12—H12B 109.5
C2—C1—H1B 109.5 C8—C12—H12C 109.5
N2—C2—C1 109.4 (2) H12A—C12—H12B 109.5
N2—C2—H2A 109.8 H12A—C12—H12C 109.5
N2—C2—H2B 109.8 H12B—C12—H12C 109.5
C1—C2—H2A 109.8 C14—C13—N1 119.1 (2)
C1—C2—H2B 109.8 C18—C13—N1 122.0 (2)
H2A—C2—H2B 108.2 C18—C13—C14 118.9 (2)
N1—C3—H3A 109.7 C13—C14—C19 121.6 (2)
N1—C3—H3B 109.7 C15—C14—C13 118.4 (2)
N1—C3—C4 109.7 (2) C15—C14—C19 119.9 (2)
H3A—C3—H3B 108.2 C14—C15—H15 118.6
C4—C3—H3A 109.7 C16—C15—C14 122.9 (2)
C4—C3—H3B 109.7 C16—C15—H15 118.6
N2—C4—C3 109.1 (2) C15—C16—C20 121.2 (2)
N2—C4—H4A 109.9 C17—C16—C15 117.6 (3)
N2—C4—H4B 109.9 C17—C16—C20 121.2 (3)
C3—C4—H4A 109.9 C16—C17—H17 119.6
C3—C4—H4B 109.9 C18—C17—C16 120.8 (3)
H4A—C4—H4B 108.3 C18—C17—H17 119.6
C6—C5—N2 119.0 (2) C13—C18—H18 119.3
C10—C5—N2 122.2 (2) C17—C18—C13 121.4 (2)
C10—C5—C6 118.7 (2) C17—C18—H18 119.3
C5—C6—C11 121.8 (2) C14—C19—H19A 109.5
C7—C6—C5 118.4 (2) C14—C19—H19B 109.5
C7—C6—C11 119.7 (2) C14—C19—H19C 109.5
C6—C7—H7 118.5 H19A—C19—H19B 109.5
C8—C7—C6 123.1 (2) H19A—C19—H19C 109.5
C8—C7—H7 118.5 H19B—C19—H19C 109.5
C7—C8—C9 117.4 (2) C16—C20—H20A 109.5
C7—C8—C12 121.4 (2) C16—C20—H20B 109.5
C9—C8—C12 121.2 (3) C16—C20—H20C 109.5
C8—C9—H9 119.5 H20A—C20—H20B 109.5
C10—C9—C8 121.0 (3) H20A—C20—H20C 109.5
C10—C9—H9 119.5 H20B—C20—H20C 109.5

Funding Statement

This work was funded by The University of Winnipeg grant .

References

  1. Bondi, A. (1964). J. Phys. Chem. 68, 441–451.
  2. Bruker (2015). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.
  3. Cavallo, G., Metrangolo, P., Milani, R., Pilati, T., Priimagi, A., Resnati, G. & Terraneo, G. (2016). Chem. Rev. 116, 2478–2601. [DOI] [PMC free article] [PubMed]
  4. Das, B., Venkateswarlu, K., Majhi, A., Siddaiah, V. & Reddy, K. R. (2007). J. Mol. Catal. A: Chem. 267, 30–33.
  5. Day, G. S., Pan, B., Kellenberger, D. L., Foxman, B. M. & Thomas, C. M. (2011). Chem. Commun. 47, 3634–3636. [DOI] [PubMed]
  6. Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K. & Puschmann, H. (2009). J. Appl. Cryst. 42, 339–341.
  7. Fulmer, G. R., Miller, A. J. M., Sherden, N. H., Gottlieb, H. E., Nudelman, A., Stoltz, B. M., Bercaw, J. E. & Goldberg, K. I. (2010). Organometallics, 29, 2176–2179.
  8. Grant, S. M. & Clissold, S. P. (1989). Drugs, 37, 310–344. [DOI] [PubMed]
  9. Hooper, D. C. & Wolfson, J. S. (1991). N. Eng. J. Med. 324, 384–394. [DOI] [PubMed]
  10. Humphrey, G. R. & Kuethe, J. T. (2006). Chem. Rev. 106, 2875–2911. [DOI] [PubMed]
  11. Kang, E. T., Neoh, K. G. & Tan, K. L. (1998). Prog. Polym. Sci. 23, 277–324.
  12. Llabres-Campaner, P. J., Ballesteros-Garrido, R., Ballesteros, R. & Abarca, B. (2017). Tetrahedron, 73, 5552–5561.
  13. Mukherjee, A., Dixit, K., Sarma, S. P. & Desiraju, G. R. (2014). IUCrJ, 1, 228–239. [DOI] [PMC free article] [PubMed]
  14. Nayak, S. K., Prathapa, S. J. & Guru Row, T. N. (2009). J. Mol. Struct. 935, 156–160.
  15. Safko, J. P. & Pike, R. D. (2012). J. Chem. Crystallogr. 42, 981–987.
  16. Sheldrick, G. M. (2015a). Acta Cryst. A71, 3–8.
  17. Sheldrick, G. M. (2015b). Acta Cryst. C71, 3–8.
  18. Tikhomirova, R. G. (1971). Zh. Org. Khim. 7, 1480–1483.
  19. Türkmen, H. & Çetinkaya, B. (2006). J. Organomet. Chem. 691, 3749–3759.
  20. Wirth, S., Barth, F. & Lorenz, I.-P. (2012). Dalton Trans. 41, 2176–2186. [DOI] [PubMed]
  21. Xu, C., Liu, Z., Torker, S., Shen, X., Xu, D. & Hoveyda, A. H. (2017). J. Am. Chem. Soc. 139, 15640–15643. [DOI] [PubMed]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Crystal structure: contains datablock(s) 1, 2. DOI: 10.1107/S2056989018011404/lh5879sup1.cif

e-74-01276-sup1.cif (975.1KB, cif)

Structure factors: contains datablock(s) 1. DOI: 10.1107/S2056989018011404/lh58791sup2.hkl

e-74-01276-1sup2.hkl (232.2KB, hkl)

Structure factors: contains datablock(s) 2. DOI: 10.1107/S2056989018011404/lh58792sup3.hkl

e-74-01276-2sup3.hkl (262.5KB, hkl)

CCDC references: 1861254, 1861253

Additional supporting information: crystallographic information; 3D view; checkCIF report


Articles from Acta Crystallographica Section E: Crystallographic Communications are provided here courtesy of International Union of Crystallography

RESOURCES